These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 8107462)
1. Response of the Emit II amphetamine/methamphetamine assay to specimens collected following use of Vicks inhalers. Poklis A; Jortani SA; Brown CS; Crooks CR J Anal Toxicol; 1993 Sep; 17(5):284-6. PubMed ID: 8107462 [TBL] [Abstract][Full Text] [Related]
2. Response of EMIT amphetamine immunoassays to urinary desoxyephedrine following Vicks inhaler use. Poklis A; Moore KA Ther Drug Monit; 1995 Feb; 17(1):89-94. PubMed ID: 7725384 [TBL] [Abstract][Full Text] [Related]
3. Stereoselectivity of the TDxADx/FLx Amphetamine/Methamphetamine II amphetamine/methamphetamine immunoassay--response of urine specimens following nasal inhaler use. Poklis A; Moore KA J Toxicol Clin Toxicol; 1995; 33(1):35-41. PubMed ID: 7837311 [TBL] [Abstract][Full Text] [Related]
4. Methamphetamine and amphetamine isomer concentrations in human urine following controlled Vicks VapoInhaler administration. Smith ML; Nichols DC; Underwood P; Fuller Z; Moser MA; Flegel R; Gorelick DA; Newmeyer MN; Concheiro M; Huestis MA J Anal Toxicol; 2014 Oct; 38(8):524-7. PubMed ID: 25217541 [TBL] [Abstract][Full Text] [Related]
6. Analytical performance evaluation of EMIT II monoclonal amphetamine/methamphetamine assay: more specificity than EMIT d.a.u. monoclonal amphetamine/methamphetamine assay. Dasgupta A; Saldana S; Kinnaman G; Smith M; Johansen K Clin Chem; 1993 Jan; 39(1):104-8. PubMed ID: 8419030 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Abbott ADx Amphetamine/Methamphetamine II abused drug assay: comparison to TDx, EMIT, and GC/MS methods. Przekop MA; Manno JE; Kunsman GW; Cockerham KR; Manno BR J Anal Toxicol; 1991; 15(6):323-6. PubMed ID: 1779660 [TBL] [Abstract][Full Text] [Related]
8. GC-MS determination of amphetamine and methamphetamine in human urine for 12 hours following oral administration of dextro-methamphetamine: lack of evidence supporting the established forensic guidelines for methamphetamine confirmation. Valentine JL; Kearns GL; Sparks C; Letzig LG; Valentine CR; Shappell SA; Neri DF; DeJohn CA J Anal Toxicol; 1995; 19(7):581-90. PubMed ID: 8577182 [TBL] [Abstract][Full Text] [Related]
9. Resolution of methamphetamine stereoisomers in urine drug testing: urinary excretion of R(-)-methamphetamine following use of nasal inhalers. Fitzgerald RL; Ramos JM; Bogema SC; Poklis A J Anal Toxicol; 1988; 12(5):255-9. PubMed ID: 3226121 [TBL] [Abstract][Full Text] [Related]
10. Buflomedil interference with the monoclonal EMIT d.a.u. amphetamine/methamphetamine immunoassay. Papa P; Rocchi L; Mainardi C; Donzelli G Eur J Clin Chem Clin Biochem; 1997 May; 35(5):369-70. PubMed ID: 9189741 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of six commercial amphetamine and methamphetamine immunoassays for cross-reactivity to phenylpropanolamine and ephedrine in urine. D'Nicuola J; Jones R; Levine B; Smith ML J Anal Toxicol; 1992; 16(4):211-3. PubMed ID: 1501473 [TBL] [Abstract][Full Text] [Related]
12. Metabolic profile of amphetamine and methamphetamine following administration of the drug famprofazone. Greenhill B; Valtier S; Cody JT J Anal Toxicol; 2003 Oct; 27(7):479-84. PubMed ID: 14607003 [TBL] [Abstract][Full Text] [Related]
13. Oral fluid with three modes of collection and plasma methamphetamine and amphetamine enantiomer concentrations after controlled intranasal l-methamphetamine administration. Newmeyer MN; Concheiro M; da Costa JL; Flegel R; Gorelick DA; Huestis MA Drug Test Anal; 2015 Oct; 7(10):877-83. PubMed ID: 25786659 [TBL] [Abstract][Full Text] [Related]
14. Methamphetamine and amphetamine derived from the metabolism of selegiline. Romberg RW; Needleman SB; Snyder JJ; Greedan A J Forensic Sci; 1995 Nov; 40(6):1100-2. PubMed ID: 8522918 [TBL] [Abstract][Full Text] [Related]
15. Ranitidine interference with the monoclonal EMIT d.a.u. amphetamine/methamphetamine immunoassay. Poklis A; Hall KV; Still J; Binder SR J Anal Toxicol; 1991; 15(2):101-3. PubMed ID: 2051743 [TBL] [Abstract][Full Text] [Related]
16. Differentiation of amphetamine/methamphetamine and other cross-immunoreactive sympathomimetic amines in urine samples by serial dilution testing. Woodworth A; Saunders AN; Koenig JW; Moyer TP; Turk J; Dietzen DJ Clin Chem; 2006 Apr; 52(4):743-6. PubMed ID: 16455869 [TBL] [Abstract][Full Text] [Related]
17. Chirality of methamphetamine and amphetamine from workplace urine samples. Cooke BJ J Anal Toxicol; 1994; 18(1):49-51. PubMed ID: 8127085 [TBL] [Abstract][Full Text] [Related]
18. Urinary excretion of d-amphetamine following oral doses in humans: implications for urine drug testing. Poklis A; Still J; Slattum PW; Edinboro LF; Saady JJ; Costantino A J Anal Toxicol; 1998 Oct; 22(6):481-6. PubMed ID: 9788523 [TBL] [Abstract][Full Text] [Related]
19. Reagent lot-to-lot variability in sensitivity for amphetamine with the Syva Emit II Monoclonal Amphetamine/Methamphetamine assay. Singh J J Anal Toxicol; 1997; 21(2):174-5. PubMed ID: 9083839 [No Abstract] [Full Text] [Related]
20. Fluorescence polarization immunoassay evaluated for screening for amphetamine and methamphetamine in urine. Caplan YH; Levine B; Goldberger B Clin Chem; 1987 Jul; 33(7):1200-2. PubMed ID: 3297420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]